IHL 0.00% 4.1¢ incannex healthcare limited

Ann: IHL-42X positive phase 2 clinical trial results, page-81

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 894 Posts.
    lightbulb Created with Sketch. 469
    Big fan of Malka's post as well, but I just don't see how we don't become a takeover target any time from now. Strong phase 2 efficacy against the massive OSA market with tremendous unmet need is too significant to let IHL go on its merry way IMO, doubly so with the PR campaign kicking off in the states, and the tremendous war chest owned by Big Pharma. Phase 2 is the hot spot for takeovers as well.

    Would love to see the BOD take us all the way but hard to envisage for me anyway. All IMO. A great day for holders regardless!
 
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.